About Us

BioTraceIT™ values the capacity to improve medical care and interventions by quantifying pain ultimately impacting quality of life and wellness. BioTraceIT™ focuses on novel technologies at the cutting edge of wearable health care. We deem new solutions as paramount to new paradigms. By measuring pain, we quantify wellness.
Deb Dullen
President & CEO

Deborah is the co-founder of the BioTraceIT™ team, formed in 2014. She brings over twenty years of experience in both the biotech and medical device fields with expertise in business development, sales, R&D, and global market entry. Deborah has a broad background from devices with J&J DePuy-Synthes to pharmaceutical, proteomics and genomics with Applied Biosystems and Eli Lilly.

Working with thousands of sales individuals she has participated and led multiple product launches and developed market strategies resulting in blockbuster products and a broad global business network. Deb has founded other successful start-ups, including Imtakt Corporation, a top research consumable company in Asia-Pacific. Deb’s thoughts about medical device start-ups, “Nothing good comes easy, but my whole career has been in healthcare and helping others is worth it.”

Lynn R. Zieske, PhD
VP & CO of Commercial Research Solutions

Multifaceted leader with over 30 years’ experience directing scientific content, product & application development, and commercial life cycles from concept to end of life in industry leading life science corporations or small start-up settings. Unique blend of technical experience and executive management skill to lead cross-functional teams to execute in-depth analyses, develop strategic tactics and implement proactive innovative solutions either scientifically or commercially. Most recently brought Singulex to market for acquisition by Millipore.

Leonard J. Shore
Vice President and General Counsel

Leonard Shore is cofounder of BioTraceIT™. He is an attorney with over 30 years of experience in the private sector. Leonard and Deborah teamed to form BioTraceIT™. Mr. Shore has acted as general counsel (and investor) to several high-tech startups. He has been general counsel to four companies which became publicly traded (OTC) entities, including Nastech Pharmaceutical, one of the first companies to seek FDA approval to utilize nasal delivery of recognized pharmaceuticals.

John J. Picchiottino, MSEE
Director of Engineering

John has been an electrical engineer associated with the development and manufacturing of biofeedback devices since 1969 and has received numerous FDA 510(k) approvals for products he developed.  He has expertise in the design, production and sale of medical electronic instrumentation for recording low level electro-physiologic signals.  He worked closely on PainTrace® for many years.  John brings a wealth of knowledge in hardware technologies to our team.

Sherri Matis-Mitchell, PhD
Data Analytics Scientist

Innovation has been a constant partner in Sherri’s career as a researcher in the biomedical sciences. She has received multiple awards in leadership, text analytics, and decision support, including a R&D 100 Award from Oak Ridge National Laboratory for innovation in predictive modeling during the 17+ years spent in AstraZeneca’s R&D. Diversity is also a common theme in Sherri’s work where she has merged tools, methodologies, information, and analytics from many disparate disciplines to create knowledge and gain insight to solve problems. Most importantly, Sherri is achieving her lifelong goal to reduce sickness and pain plus improve quality in both human and animal lives by working to develop predictive systems for analysis as well as new treatments for disease by exploiting and extracting legacy data and information from published literature and structured sources.

Minakshi Mohanty
Bio-sensor and Design Engineer

As a Bio-sensor and Design Engineer at BioTraceIT™, Minakshi’s work involves product design, development, and clinical research. Prior to joining BioTraceIT™, Minakshi worked with the Department of Ultrasound at Thomas Jefferson University Hospitals where she was responsible for developing image processing algorithms for diagnostic ultrasound systems. She holds a MS in Biomedical Engineering from Drexel University and a B.E in Biomedical Engineering from Manipal University, India. In her free time, she enjoys swimming, reading and traveling.

Greg Milette
Software and Applications Engineer

Greg Milette has 15 years of software development experience. Recently, he has built mobile applications, voice user interfaces, and connected IoT devices for nearly a dozen companies. One of these applications is a speech-driven recipe assistant app that has had over 100,000 downloads. Greg is also the author of Professional Android Sensor Programming, a book which describes how to develop mobile apps with speech recognition capabilities.

Dr. Charles E. Short DVM, MS, PhD, DACVA, DECVA
Chair of Animal Scientific Advisory Board

As a member of the BioTraceIt team, Dr. Short brings over 50 years of experience in clinical anesthesia and pain management, teaching and research.  He is an emeritus professor of veterinary anesthesia and pain management at Cornell University.  He has a broad background in the development of new anesthetics and analgesics cooperating with the pharmaceutical industry and government agencies. These works have resulted in over 350 publications and over 740 presentations and lectures for professional groups in the USA and other countries.   He is one of the founding charter diplomates of the American College of Veterinary Anesthesia and Analgesia and a founding diplomate of the European College of Veterinary Anesthesia and Analgesia.

He was one of the co-founders of the International Veterinary Academy of Pain Management. His career objectives have been to improve the quality of anesthesia and pain management through better medications, monitoring technologies  and education. These have been applied through instruction for veterinary students, interns, residents and graduates.He continues his career through additional lectures and collaboration with colleagues in both veterinary and medical colleges and the pharmaceutical industry.

News and Blog

BioTraceIT™ Corporation

PainTrace® The only patented devices and technologies for non-invasive and continuous pain monitoring.

Subscribe to our Newsletter

Contact Us


Follow Us

The patented PainTrace® and BioTraceIT™ technology and software application are covered by U.S. Patent and other pending U.S. and International patents.

* Per FDA guidelines in humans this product is For Research Purpose Only.  
* Per FDA Center for Veterinary Medicine this product is Not for Human Use.